Viewing Study NCT01663727


Ignite Creation Date: 2025-12-25 @ 5:11 AM
Ignite Modification Date: 2026-02-27 @ 1:35 PM
Study NCT ID: NCT01663727
Status: COMPLETED
Last Update Posted: 2019-01-22
First Post: 2012-08-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer
Sponsor:
Organization: